Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C

Hepatology

Volumn 23, Issue 2, 1996, Pages 210-217

  Larrea, Esther ^a   Garcia, Nicolás ^a   Qian, Cheng ^a   Civeira, Maria P ^a   Prieto, Jesús ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CYTOKINE; HEPATITIS C ANTIBODY; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030052322     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008591843     Document Type: Article

References (25)

1. Camussi G, Albano E, Tetta C, Bussolino F. The molecular action of tumor necrosis factor alpha. Eur J Biochem 1991;202:3-14.
2. Cerami A. Inflammatory cytokines. Clin Immunol Immunopathol 1992;62(suppl):S3-S10.
3. Nokta M, Matzke D, Jennings M, Schlick E, Nadler PI, Pollard R. In vivo administration of tumor necrosis factor-alpha is associated with antiviral activity in human peripheral mononuclear cells. Soc Exp Biol Med 1991;197:144-149.
4. Ruhin BY. TNF and viruses: multiple interrelationships. In: Aggarwal BB, Vilcek J, eds. Tumor necrosis factors. New York: Dekker, 1992:331-340.
5. Wong GHW, Krowka JF, Stites DP, Goeddel DV. In vitro antihuman immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol 1988;140:120-125.
6. Backer S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991;147:4307-4312.
7. Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, Gemsa D. Coxsackievirus B3-induced production of tumor necrosis factor-alpha, IL-lbeta, and IL-6 in human monocytes. J Immunol 1992;148:2270-2277.
8. Gong JH, Sprenger H, Hinder F, Bender A, Schmidt A, Horch S, Nain M, et al. Influenza A virus infection of macrophages enhanced tumor necrosis factor-alpha (TNF-α) gene expression and lipopolysaccharide-triggered TNF-α release. J Immunol 1991;147:3507-3513.
9. Gosselin J, Flamand L, D'Addario M, Hiscott J, Menezes J. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha. J Clin Invest 1992;89:1849-1856.
10. Nagakawa J, Hishinuma I, Hirota K, Miyamoto K, Yamanaka T, Tsukidate K, Katayama K, et al. Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice. Gastroenterology 1990;99:758-765.
11. Devictor D, Decimo D, Sebire G, Tardieu M, Hadchouel M. Enhanced tumor necrosis factor alpha in coronavirus but not in paracetamol-induced acute hepatic necrosis in mice. Liver 1992;12:205-208.
12. Goto M, Takei Y, Kawano S, Tsuji S, Fukui H, Fushimi H, Nishimura Y, et al. Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotropic liver transplantation in the rat. HEPATOLOGY 1992;16:487-493.
13. Muto Y, Meager A, Eddleston ALWF, Noun-Aria KT, Alexander GJM, Williams R, Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988;9:72-74.
14. Bird GLA, Sheron N, Goka AKJ, Alexander GJ, Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990;112:917-920.
15. Mizuhara H, O'Neille E, Seki N, Ogawa T, Kusonoki C, Otsuka K, Satoh S, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factor and protection by interleukin-6. J Exp Med 1994;179:1529-1537.
16. Sheron N, Lau J, Daniels H, Goka J, Eddleston A, Alexander GJM, Williams R. Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol 1991;12:251-255.
17. De la Mata M, Meager A, Rolando N, Daniels HM, Nouri-Aria KT, Goka AKJ, Eddleston ALWF, et al. Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection. Clin Exp Immunol 1990;82:479-484.
18. Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. HEPATOLOGY 1989;10:769-773.
19. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, Huber Ch. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-274.
20. Gil B, Quian C, Riezu-Boj JI, Civeira MP, Prieto J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. HEPATOLOGY 1993;18:1050-1054.
21. Qian C, Camps J, Maluenda MD, Civeira MP, Prieto J. Replication of hepatitis C virus in peripheral blood mononuclear cells, effect of alpha-interferon therapy. J Hepatol 1992;16:380-383.
22. Fong TL, Shindo M, Feinstone SM, Hoofnagle JH, Di Bisceglie AM. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest 1991;88:1058-1060.
23. Camps J, Crisóstomo S, García-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Prediction of the response of chronic hepatitis C to interferon alpha: a statistical analysis of pretreatment variables. Gut 1993;34:1714-1717.
24. Knodell R, Ishak K, Black W, Chen T, Craig R, Kaplowitz N, Kiernan T, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
25. Chomczynsky P, Sacchi N. Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.